Phase IIa Study of Metastatic Breast Cancer
The purpose of this study is to obtain evidence from test article with efficacy in Metastatic Breast Cancer patients. The average of all changes from baseline to post-treatment evaluations in global health/quality of life (QoL) subscale assessed by self-administered European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 (EORTC-QLQ-C30).
THL-P with Metastatic Breast Cancer refractory
100 Clinical Results associated with Taiwan THL Co.LTd.
0 Patents (Medical) associated with Taiwan THL Co.LTd.
100 Deals associated with Taiwan THL Co.LTd.
100 Translational Medicine associated with Taiwan THL Co.LTd.